Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $76.75 million. The enterprise value is $180.47 million.

Market Cap	76.75M
Enterprise Value	180.47M

Important Dates

The next estimated earnings date is Tuesday, August 4, 2026, after market close.

Earnings Date	Aug 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Gossamer Bio has 488.85 million shares outstanding. The number of shares has increased by 1.70% in one year.

Current Share Class	488.85M
Shares Outstanding	488.85M
Shares Change (YoY)	+1.70%
Shares Change (QoQ)	+3.32%
Owned by Insiders (%)	1.54%
Owned by Institutions (%)	33.82%
Float	281.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.38
Forward PS	4.08
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.20

Current Ratio	2.20
Quick Ratio	1.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.58

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-52.29%
Return on Invested Capital (ROIC)	-89.98%
Return on Capital Employed (ROCE)	-236.64%
Weighted Average Cost of Capital (WACC)	7.30%
Revenue Per Employee	$342,821
Profits Per Employee	-$1.11M
Employee Count	162
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	-88,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.46% in the last 52 weeks. The beta is 2.00, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y)	2.00
52-Week Price Change	-88.46%
50-Day Moving Average	0.26
200-Day Moving Average	1.71
Relative Strength Index (RSI)	33.79
Average Volume (20 Days)	16,874,450

Short Selling Information

The latest short interest is 56.21 million, so 11.50% of the outstanding shares have been sold short.

Short Interest	56.21M
Short Previous Month	62.82M
Short % of Shares Out	11.50%
Short % of Float	19.98%
Short Ratio (days to cover)	5.49

Income Statement

In the last 12 months, Gossamer Bio had revenue of $55.54 million and -$180.40 million in losses. Loss per share was -$0.78.

Revenue	55.54M
Gross Profit	55.54M
Operating Income	-171.31M
Pretax Income	-180.48M
Net Income	-180.40M
EBITDA	-171.29M
EBIT	-171.31M
Loss Per Share	-$0.78

Full Income Statement

Balance Sheet

The company has $99.22 million in cash and $202.93 million in debt, giving a net cash position of -$103.72 million or -$0.21 per share.

Cash & Cash Equivalents	99.22M
Total Debt	202.93M
Net Cash	-103.72M
Net Cash Per Share	-$0.21
Equity (Book Value)	-161.48M
Book Value Per Share	-0.69
Working Capital	68.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$170.26 million and capital expenditures -$53,000, giving a free cash flow of -$170.32 million.

Operating Cash Flow	-170.26M
Capital Expenditures	-53,000
Depreciation & Amortization	23,000
Net Borrowing	n/a
Free Cash Flow	-170.32M
FCF Per Share	-$0.35

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-308.46%
Pretax Margin	-324.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.70%
Shareholder Yield	-1.70%
Earnings Yield	-235.05%
FCF Yield	-221.91%

Analyst Forecast

The average price target for Gossamer Bio is $3.86, which is 2,358.60% higher than the current price. The consensus rating is "Hold".

Price Target	$3.86
Price Target Difference	2,358.60%
Analyst Consensus	Hold
Analyst Count	7
Revenue Growth Forecast (3Y)	39.79%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gossamer Bio has an Altman Z-Score of -18.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.54
Piotroski F-Score	1